TOVX

AMEX · Biotechnology

Theriva Biologics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.22

+0.02 (+10.06%)

As of Feb 8, 2:30 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 75%

Hold 2 25%

Sell 0 0%

Price Target

Analyst Price Target +17,504.5% upside

Low Target $26.34

Average Target $38.73

High Target $46.19

Current Price $0.22

Current
$0.22

Target
$38.73

$26.34 $38.73 avg $46.19

Scenario Analysis

Bear Case

$26.34

11,872.7%

Low target

Base Case

$38.73

+17,504.5%

Avg target

Bull Case

$46.19

+20,895.5%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$32.39

-99.3% from high

52-Week Low

$17.11

+-98.7% from low

Target vs 52W High

$38.73

+19.6% vs high

Next Earnings Report

Mar 4, 2026 · After Market Close

16d

until earnings

EPS Est: $-0.44

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%